VanEck Genomics and Healthcare Innovators UCITS ETF

CURE XETRA Healthcare & Biotech United States
17.73

3x leveraged ETF aiming to provide amplified exposure to U.S. healthcare and biotechnology stocks.

Performance & Momentum

6 Months 7.82 %
1 Year 3.24 %
3 Years 8.53 %
5 Years 17.13 %

Similar stocks to VanEck Genomics and Healthcare Innovators UCITS ETF

Anantys Community

Be the first to share your analysis on VanEck Genomics and Healthcare Innovators UCITS ETF.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases